This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
25 Mar 2011

New Measures to Boost UK Pharma Innovation

New measures in the budget have been made to benefit pharma industry in the UK including an additional ?100m for science innovation facilities.

Innovation in the UK pharmaceutical industry is set to receive a boost thanks to new measures described in the budget by Chancellor George Osborne this week.

 

An additional £100m is to be invested in science innovation facilities within the country, and reducing clinical trial approval time frames from 600 days to 60 days are moves that hope to attract pharmaceutical companies into the country.

 

Other measures made to benefit pharmaceutical companies based in the UK include a reduction in corporation tax over the next three years to 23%, as well as capital allowances and relaxed planning permission restraints for facilities built within designated 'enterprise zones'.

Related News